Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Malignant Myoepithelioma: A Rare Salivary Gland Cancer

What is Malignant Myoepithelioma? Malignant Myoepithelioma, also known as Myoepithelial Carcinoma, is a rare form of cancer primarily affecting the salivary glands, particularly the parotid gland. It may also arise in soft tissues, submandibular glands, or minor...

Our New Resource Page for Neuroectodermal Olfactory Neuroblastoma

Neuroectodermal Olfactory Neuroblastoma is a rare cancer that originates in the nasal cavity, potentially impairing the sense of smell. It can invade nearby tissues, including the eyes, brain, neck, lungs, or bones. This cancer accounts for approximately 3% of all...

Neuroectodermal Olfactory Neuroblastoma: A Nasal Cavity Cancer

What is Neuroectodermal Olfactory Neuroblastoma? Neuroectodermal Olfactory Neuroblastoma is a rare cancer that originates in the nasal cavity, potentially impairing the sense of smell. It can invade nearby tissues, including the eyes, brain, neck, lungs, or bones....

Our New Resource Page for Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT), is a rare and highly aggressive form of ovarian cancer. This subtype predominantly affects young women and is frequently associated with hypercalcemia, or elevated calcium levels in the blood. Many...

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)

What is Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)? Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT), is a rare and highly aggressive form of ovarian cancer. This subtype predominantly affects young women and is frequently associated...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter